Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses (BLEEDING Study)

NCT04380779 is registered in ClinicalTrials.gov with Manuel Monreal as lead sponsor.

NCT NCT04380779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04380779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses (BLEEDING Study)
Lead sponsor
Manuel Monreal
Phase
Observational
Overall status
Completed
Start date
April 13, 2020
Completion date
October 13, 2020
Enrollment
2,430 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19